CTN :42904123
23 Dec, 2025
90.00 Crore
Tender For e-bid for rate contract cum supply and empanelment of firms for drugs and medicines - dexamethasone inj ip 8mg/2ml [39], surgical spirit ip (500 ml) [252], biphasic isophane insulin inj ip (30 % soluble insulin and 70 % isophane insulin) inj. 40 iu/ml(r-dna origin) [279], calcium and class="text-red-selected">vitamin d3 suspension (ea
ch 5 ml
contains
cal
cium
carbonate equivalent to elemental
cal
cium 250 mg,
class="text-red-sele
cted">vitamin d3 125 iu) [441], surfa
ctant for intratre
cheal instillation (natural bovine lung surfa
ctant) [635], dried fa
ctor viii fra
ction ip (iv use) 500 iu/vial [688], re
combinant f ix 500 iu with diluent [748], 3rd generation re
combinant f viii 1000 iu with diluent [750], leurprolide a
cetate depot 3.75 mg [775], gatifloxa
cin 0.30% and prednisolone a
cetate 1% ophthalmi
c suspension [nrd-103], hpm
c 0.3% eye drop [nrd-104], vori
conazole 1 % w/v (lyophilized) 30mg eye drop [nrd-119],
chlorampheni
col 1%, polymyxin b sulphate (10000 units) and dexamethasone 0.1% sodium phosphate eye ointment [nrd-123],
carmustine 100 mg inj. ip [nrd-175], detemir insuline 100iu/ml inje
ction 3ml [nrd-214], fludarabine phosphate inje
ction 100mg inj. ip [nrd-237], fludarabine phosphate inje
ction 50mg inj. ip [nrd-238], methotrexate 1000 mg inj. ip [nrd-289], inj. methylprednisolone a
cetate 125 mg i.p. (ea
ch vial
contains methylprednisolone a
cetate 125 mg) [nrd-292], mitomy
cin 40 mg inj. ip [nrd-297], plerixafor 24 mg inj. [nrd-338], rasburi
case 1.5 mg inj. [nrd-347], re
combinant lh 75iu inj. [nrd-351], trabe
ctedin 1 mg inj. [nrd- 387], trypan blue 0.06% w/v inje
ction [nrd-393], levosalbutamol 50m
cg. and ipratropium 40m
cg. mdi [nrd-425], gly
copyrronium inhalation solution 25m
cg 2 ml [nrd-458], amorolfine 0.25%
cream [nrd-46], gly
coli
c a
cid 6%
cream [nrd-51], hydroquinone 2%
cream usp [nrd-53], everolimus 10mg tab./
cap. [nrd-531], da
comitinib 15 mg tab., methimazole 10mg tab. usp [nrd-678], rasagiline1mg tab. [nrd-756], regorafenib 40 mg tab. [nrd- 757], ulipristal 5mg tab. [nrd-808], brinozolamide 1% w/v and brimonidine tartrate 0.2% w/v ophthalmi
c suspension [nrd-98], tri
clofos oral suspension500 mg/ 5ml in 30ml syrup i.p.[nrd-522], etori
coxib+thio
col
chi
coside(60+8 mg) tab. [nrd-630], levodopa and
carbidopa and enta
capone 100mg/25mg/200mg tab. [nrd-662], ni
corandil 5mg tab. i.p. [nrd-704], nifidipine
capsule 10mg, diastase, pepsin with simethi
cone 15ml dropea
ch ml
contains diastase (1:1200) 33.33mg, pepsin (1:3000) 5mg& simethi
cone emulsion 40mg [nrd-71], nitazoxanide 500mg tab.[nrd-713], hydroxyzine hydro
chloride oral solution / drop 6mg/ml [nrd-76], trimetazidine hydro
chloride modified release (
cr/sr/pr) 60 mg
capsule/tablet [nrd-805], ferrous as
corbate and foli
c a
cid drops 15ml (ea
ch ml
contains ferrous as
corbate 10mg and foli
c a
cid 100m
cg) [nrd-81], zin
c 50mg tab. [nrd-818],
class="text-red-sele
cted">vitamin e 50mg/ml drops 15ml [nrd-83], gly
copegylated extended half life fa
ctor viii 1000 iu